Viewing Study NCT00226460


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-05-23 @ 2:28 PM
Study NCT ID: NCT00226460
Status: COMPLETED
Last Update Posted: 2015-03-18
First Post: 2005-09-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2, Double-blind, Randomized, Controlled Multi-center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.
Sponsor: Genzyme, a Sanofi Company
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: PD96-1101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View